Access to Philips Respironics EncoreAnywhere Data Improves Physician Monitoring of Patient CPAP Therapy

Philips RespironicsSomnoware, a top provider of digital health technology, announced ahead of the weekend that Philips Respironics, a global leader in the sleep and respiratory markets, has signed an agreement to grant direct access to all CPAP usage data stored in their EncoreAnywhere patient management system with consent from the physicians or health system.

“This data is fully accessible to independent and network practices alike via the new Somnoware care management module,” a media release notes. “By having access to this data, physicians can use Somnoware to setup their patients with CPAP devices faster and provide them with better long-term care.”

When using the Somnoware DME module, the DME company receives an order from the physician to have a patient set up with a CPAP device and sends the setup data to the EncoreAnywhere.

Since the portal is used for tracking the orders, the DME manufacturer is able to see if the order has been approved by the physician. If it has not been approved, then they are able to send a reminder to the physician, enabling them to expedite the order. The physician is also able to monitor the progress of the CPAP device order via the care management module—ensuring their patient receives faster treatment.

Once the patient is set up with a CPAP device, the physician is able to monitor their CPAP compliance by using the care management module.

“We are thrilled to now have access to the CPAP usage data populated by Respironics’ EncoreAnywhere. Our goal is to use this data to identify at-risk patients as early as possible,” says Subath Kamalasan, CEO of Somnoware. “Physicians that provide a higher level of intervention improve patient CPAP compliance. Our platform arms physicians with critical tools that allow them to effectively monitor and manage adherence.”

This post was written by:

- who has written 626 posts on mHealthWatch.

Contact the author